587 related articles for article (PubMed ID: 34958385)
1. Phytolectin nanoconjugates in combination with standard antifungals curb multi-species biofilms and virulence of vulvovaginal candidiasis (VVC) causing Candida albicans and non-albicans Candida.
Senthilganesh J; Kuppusamy S; Durairajan R; Subramaniyan SB; Veerappan A; Paramasivam N
Med Mycol; 2022 Jan; 60(2):. PubMed ID: 34958385
[TBL] [Abstract][Full Text] [Related]
2. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
Gao M; Wang H; Zhu L
Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
[TBL] [Abstract][Full Text] [Related]
3. Vulvovaginal candidiasis and asymptomatic vaginal colonization in Portugal: Epidemiology, risk factors and antifungal pattern.
Fernandes Â; Azevedo N; Valente A; Dias M; Gomes A; Nogueira-Silva C; Henriques M; Silva S; Gonçalves B
Med Mycol; 2022 May; 60(5):. PubMed ID: 35482711
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, antifungal susceptibility and etiology of vulvovaginal candidiasis in sub-Saharan Africa: a systematic review with meta-analysis and meta-regression.
Mushi MF; Olum R; Bongomin F
Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35781514
[TBL] [Abstract][Full Text] [Related]
6. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
Hacioglu M; Guzel CB; Savage PB; Tan ASB
Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal
Mohammadi F; Hemmat N; Bajalan Z; Javadi A
Biomed Res Int; 2021; 2021():5598907. PubMed ID: 34136569
[TBL] [Abstract][Full Text] [Related]
8. Biofilms and vulvovaginal candidiasis.
Rodríguez-Cerdeira C; Gregorio MC; Molares-Vila A; López-Barcenas A; Fabbrocini G; Bardhi B; Sinani A; Sánchez-Blanco E; Arenas-Guzmán R; Hernandez-Castro R
Colloids Surf B Biointerfaces; 2019 Feb; 174():110-125. PubMed ID: 30447520
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of citrus pectin capped copper sulfide nanoparticles against Candidiasis causing Candida biofilms.
Al-Enazi NM; Alsamhary K; Ameen F
Environ Res; 2023 May; 225():115599. PubMed ID: 36898420
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: A retrospective study over a 20 year-period.
Intra J; Sala MR; Brambilla P; Carcione D; Leoni V
J Mycol Med; 2022 Aug; 32(3):101278. PubMed ID: 35523109
[TBL] [Abstract][Full Text] [Related]
11. Plasma-based strategy for inhibiting Candida albicans growth and CaMCA1 gene expression in vitro and reducing fungal pathogenicity in a murine model of vulvovaginal candidiasis.
Ebrahimi-Shaghaghi F; Atyabi SM; Razzaghi-Abyaneh M
Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34694384
[TBL] [Abstract][Full Text] [Related]
12. Antifungal activity of cathelicidin peptides against planktonic and biofilm cultures of Candida species isolated from vaginal infections.
Scarsini M; Tomasinsig L; Arzese A; D'Este F; Oro D; Skerlavaj B
Peptides; 2015 Sep; 71():211-21. PubMed ID: 26238597
[TBL] [Abstract][Full Text] [Related]
13. Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study.
Trajano DTM; Melhem MSC; Takahashi JPF; Bonfietti LX; de Araújo MR; Corrêa VB; Araújo KBO; Barnabé V; Fernandes CG
Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36893795
[TBL] [Abstract][Full Text] [Related]
14. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
Goswami D; Goswami R; Banerjee U; Dadhwal V; Miglani S; Lattif AA; Kochupillai N
J Infect; 2006 Feb; 52(2):111-7. PubMed ID: 15908007
[TBL] [Abstract][Full Text] [Related]
15. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of Lactobacillus casei Shirota against both Candida auris and Candida spp. isolates that cause vulvovaginal candidiasis and are resistant to antifungals.
Paniágua AL; Correia AF; Pereira LC; de Alencar BM; Silva FBA; Almeida RM; de Medeiros Nóbrega YK
BMC Complement Med Ther; 2021 Sep; 21(1):237. PubMed ID: 34556109
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology, antifungal susceptibility, and ERG11 gene mutation of Candida species isolated from vulvovaginal candidiasis: Comparison between recurrent and non-recurrent infections.
Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
Microb Pathog; 2022 Sep; 170():105696. PubMed ID: 35921954
[TBL] [Abstract][Full Text] [Related]
18. Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance.
Li X; Chen S; Lyu X; Tian J
Med Mycol; 2022 Nov; 60(11):. PubMed ID: 36328948
[TBL] [Abstract][Full Text] [Related]
19. Spilanthol as a promising antifungal alkylamide for the treatment of vulvovaginal candidiasis.
Fabri RL; Freitas JCO; Lemos ASO; Campos LM; Diniz IOM; Pinto NCC; Silva TP; Palazzi C; Marchesini P; Monteiro C; Barbosa AF; Carvalho MG; Chedier LM; Araújo MGF; Apolônio ACM; Rocha VN; Melo RCN; Pinto PF
Med Mycol; 2021 Dec; 59(12):1210-1224. PubMed ID: 34468763
[TBL] [Abstract][Full Text] [Related]
20. Biofilms Formed by Isolates from Recurrent Vulvovaginal Candidiasis Patients Are Heterogeneous and Insensitive to Fluconazole.
Sherry L; Kean R; McKloud E; O'Donnell LE; Metcalfe R; Jones BL; Ramage G
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]